Francis Patrick Ostronic Cyclo Therapeutics, Inc. (CYTH) insider trading activity

Francis Patrick Ostronic is Director of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 348,771 shares of CYTH, which is worth approximately $261,578. The most recent transaction as insider was on Jun 03, 2024, when has been sold 10,743 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 349K

0% 3M change

12.89% 12M change

Total Value Held $261,578

Francis Patrick Ostronic Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 03 2024	BUY Grant, award, or other acquisition	-	10,743 Added 2.99%	348,771 Common Stock
Feb 13 2024	BUY Grant, award, or other acquisition	-	8,703 Added 2.51%	338,028 Common Stock
Nov 28 2023	BUY Grant, award, or other acquisition	-	10,262 Added 3.02%	329,325 Common Stock
Oct 20 2023	BUY Exercise of in-the-money or at-the-money derivatives securities	$42,515 $0.71 p/Share	59,881 Added 16.24%	308,952 Common Stock
Aug 18 2023	BUY Grant, award, or other acquisition	-	10,111 Added 3.75%	259,182 Common Stock
May 17 2023	BUY Grant, award, or other acquisition	-	26,700 Added 9.68%	249,071 Common Stock
Apr 20 2023	BUY Open market or private purchase	$42,515 $0.71 p/Share	59,881 Added 21.22%	222,371 Common Stock
Nov 08 2022	BUY Grant, award, or other acquisition	-	11,803 Added 6.77%	162,490 Common Stock
Sep 21 2022	BUY Open market or private purchase	$8,800 $1.76 p/Share	5,000 Added 3.21%	150,687 Common Stock
Aug 02 2022	BUY Grant, award, or other acquisition	-	7,162 Added 4.69%	145,687 Common Stock
May 20 2022	BUY Open market or private purchase	$10,100 $2.02 p/Share	5,000 Added 3.48%	138,525 Common Stock
May 03 2022	BUY Grant, award, or other acquisition	-	5,249 Added 3.78%	133,525 Common Stock
Apr 06 2022	BUY Grant, award, or other acquisition	$14,500 $2.9 p/Share	5,000 Added 3.75%	128,276 Common Stock
Feb 04 2022	BUY Grant, award, or other acquisition	$16,500 $3.3 p/Share	5,000 Added 3.9%	123,276 Common Stock
Jan 28 2022	BUY Grant, award, or other acquisition	-	5,065 Added 4.11%	118,276 Common Stock
Jan 24 2022	BUY Open market or private purchase	$7,500 $3.75 p/Share	2,000 Added 1.74%	113,211 Common Stock
Jan 19 2022	BUY Open market or private purchase	$4,528 $4.0 p/Share	1,132 Added 1.01%	111,211 Common Stock
Jan 14 2022	BUY Open market or private purchase	$6,924 $4.0 p/Share	1,731 Added 1.55%	110,079 Common Stock
Jan 14 2022	BUY Open market or private purchase	$8,548 $4.0 p/Share	2,137 Added 1.93%	108,348 Common Stock
Dec 15 2021	BUY Open market or private purchase	$11,700 $3.9 p/Share	3,000 Added 2.75%	106,211 Common Stock
Dec 10 2021	BUY Open market or private purchase	$22,000 $4.4 p/Share	5,000 Added 4.62%	103,211 Common Stock
Dec 03 2021	BUY Open market or private purchase	$4,104 $4.75 p/Share	864 Added 0.87%	98,211 Common Stock
Dec 02 2021	BUY Open market or private purchase	$19,646 $4.75 p/Share	4,136 Added 4.08%	97,347 Common Stock
Dec 01 2021	BUY Open market or private purchase	$25,000 $5.0 p/Share	5,000 Added 5.09%	93,211 Common Stock
Nov 19 2021	BUY Open market or private purchase	$55,816 $5.24 p/Share	10,652 Added 10.77%	88,211 Common Stock

FPO

Francis Patrick Ostronic

Director

Gainesville, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTH shares.

Notify only if

Value

Insider Trading

Get notified when an Cyclo Therapeutics, Inc. insider buys or sells CYTH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cyclo Therapeutics, Inc.

Track Activities on CYTH

Account